Trial Profile
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2024
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Cisplatin; Dexrazoxane; Doxorubicin; Fluorouracil; Irinotecan; Vincristine
- Indications Hepatoblastoma
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2024 Planned End Date changed from 31 Jul 2020 to 5 Mar 2025.
- 06 Mar 2024 Planned End Date changed from 31 Jul 2020 to 5 Mar 2025.
- 11 Nov 2021 Results published in the Cancer